Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 23;18(9):e1003801.
doi: 10.1371/journal.pmed.1003801. eCollection 2021 Sep.

Prevalence and incidence of young onset dementia and associations with comorbidities: A study of data from the French national health data system

Laure Carcaillon-Bentata  1 , Cécile Quintin  1 , Marjorie Boussac-Zarebska  1 , Alexis Elbaz  1   2
Affiliations

Prevalence and incidence of young onset dementia and associations with comorbidities: A study of data from the French national health data system

Laure Carcaillon-Bentata et al. PLoS Med. .

Abstract

Background: Dementia onset in those aged <65 years (young onset dementia, YOD) has dramatic individual and societal consequences. In the context of population aging, data on YOD are of major importance to anticipate needs for planning and allocation of health and social resources. Few studies have provided precise frequency estimates of YOD. The aim of this study is to provide YOD prevalence and incidence estimates in France and to study the contribution of comorbidities to YOD incidence.

Methods and findings: Using data from the French national health data system (Système National des Données de Santé, SNDS) for 76% of the French population aged 40 to 64 years in 2016 (n = 16,665,795), we identified all persons with dementia based on at least 1 of 3 criteria: anti-Alzheimer drugs claims, hospitalization with the International Classification of Diseases-10th Revision (ICD-10) dementia codes (F00 to F03, G30, G31.0, G31.1, or F05.1), or registration for free healthcare for dementia. We estimated prevalence rate (PR) and incidence rate (IR) and estimated the association of comorbidities with incident YOD. Sex differences were investigated. We identified 18,466 (PRstandardized = 109.7/100,000) and 4,074 incident (IRstandardized = 24.4/100,000 person-years) persons with prevalent and incident YOD, respectively. PR and IR sharply increased with age. Age-adjusted PR and IR were 33% (95% confidence interval (CI) = 29 to 37) and 39% (95% CI = 31 to 48) higher in men than women (p < 0.001 both for PR and IR). Cardio- and cerebrovascular, neurological, psychiatric diseases, and traumatic brain injury prevalence were associated with incident YOD (age- and sex-adjusted p-values <0.001 for all comorbidities examined, except p = 0.109 for antihypertensive drug therapy). Adjustment for all comorbidities explained more than 55% of the sex difference in YOD incidence. The lack of information regarding dementia subtypes is the main limitation of this study.

Conclusions: We estimated that there were approximately 24,000 and approximately 5,300 persons with prevalent and incident YOD, respectively, in France in 2016. The higher YOD frequency in men may be partly explained by higher prevalence of cardiovascular and neurovascular diseases, substance abuse disorders, and traumatic brain injury and warrants further investigation.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1
Age-specific prevalence (A1; A2, log scale) and incidence (B1; B2, log scale) rates of YOD in men and women (2016). Shaded regions represent 95% CIs. CI, confidence interval; YOD, young onset dementia.
Fig 2
Fig 2. Male-to-female PR (PRRM/W) and IR (IRRM/W) rate ratios, overall and by age.
Black bars represent 95% CIs. CI, confidence interval; IR, incidence rate; PR, prevalence rate.
See this image and copyright information in PMC

References

    1. Group GBDNDC. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017;16(11):877–97. doi: 10.1016/S1474-4422(17)30299-5 . - DOI - PMC - PubMed
    1. Rossor MN, Fox NC, Mummery CJ, Schott JM, Warren JD. The diagnosis of young-onset dementia. Lancet Neurol. 2010;9(8):793–806. doi: 10.1016/S1474-4422(10)70159-9 . - DOI - PMC - PubMed
    1. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013;9(1):63–75.e2. doi: 10.1016/j.jalz.2012.11.007 . - DOI - PubMed
    1. Ducharme S, Dickerson BC. The neuropsychiatric examination of the young-onset dementias. Psychiatr Clin North Am. 2015;38(2):249–64. Epub 2015/05/23. doi: 10.1016/j.psc.2015.01.002 . - DOI - PubMed
    1. Werner P, Stein-Shvachman I, Korczyn AD. Early onset dementia: clinical and social aspects. Int Psychogeriatr. 2009;21(4):631–6. doi: 10.1017/S1041610209009223 . - DOI - PubMed